Greetings on yet another edition of The Prescription!
We constantly endeavour not only to collate important information from the health and medicine world but also to create a connect with consumers all over. We welcome articles and write ups from our readers and are glad to feature them under the section titled Subscriber’s Symptoms. Mark your calendar with the upcoming events listed in our newsletter and remember to take your laughter dose in the end.
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@jagograhakjago.com
You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pooja Khaitan
Editor-in-Chief,
The Prescription
“Healthcare was moving towards “personalised” medicines and patient-care. And the pharmaceutical industry had an important role to play in delivering responsible healthcare.”
A.Vaidheesh,
OPPI President
The confusion caused by look-alike and sound-alike (LASA) drugs has resulted in medication errors, leading to harm to patients and causing death. This has made the Drugs Controller General of India (DCGF) ask for an amendment to the Drugs and Cosmetics Act to regulate brand names of pharmaceutical products.
The department of biotechnology (DBT) has put out India’s first draft guidelines on evaluation of “nanopharmaceuticals in India” for public consultation. Nanopharmaceuticals are drug preparations that use nanoparticles the size of 1 to 100 nm as carriers for targetted delivery of an active pharmaceutical ingredient.
US FDA Takes Steps To Help Reduce Risks Associated With Surgical Staplers And Implantable Staples
Maryland, 8 March 2019: Today, the U.S. Food and Drug Administration issued a Letter to Health Care Providers to alert them that the agency is aware of an increasing number of medical device reports associated with the use of surgical staplers for internal use and implantable surgical staples—common devices used in many surgeries—and to provide updated recommendations to help reduce risks associated with their use.
US FDA Approves Esketamine Nasal Spray For Treatment-Resistant Depression
WASHINGTON, 5 MARCH 2019: The US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for esketamine nasal spray (Spravato), in conjunction with an oral antidepressant, as a therapy for patients with treatment-resistant depression.
US FDA Finds Cancer-Causing Toxin In Hetero's Blood Pressure Drugs
Washington, 2 March 2019: US health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly used drugs to treat hypertension.
EMA Publishes First Guidance On New Rules For Certain Medical Devices
UK, 2 March 2019: The European Medicines Agency (EMA) has published the first of a series of guidance documents to help applicants prepare for obligations stemming from the new EU regulations on medical devices.
Counterfeit Fentanyl Pills Continue To Claim Lives In Arizona
March 7, 2019: According to CBS 5 Investigates, counterfeit Percocet pills laced with fentanyl have wreaked havoc in communities across Arizona, claiming lives, but also leaving individuals with lasting brain damage. The pills, called “M-30s” on the streets, are counterfeits made with fentanyl, a drug 100 times more potent than morphine.
South Dakota Man Sentenced To 121 Months After Trafficking In Fentanyl Pills And Other Drug
March 5, 2019: Sioux City Journal reported that a Yankton, South Dakota man will spend more than ten years in federal prison for trafficking in fentanyl and other drugs. Cory Poelstra pleaded guilty in federal court to conspiracy to distribute a controlled substance.
Frequently Asked Questions
Q1. What is NABH?
Ans: NABH (National Accreditation Board for Hospitals & Healthcare Providers) is a constituent board of Quality Council of India Certification, set up to establish and operate accreditation programme for healthcare organizations. NABH was established in 2006. Organisations like the Quality Council of India (QCI) and its National Accreditation Board for Hospitals & Healthcare Providers have designed an exhaustive healthcare standard for hospitals and healthcare providers. This standard consists of stringent 600 plus objective elements for the hospital to achieve in order to get the NABH accreditation. These standards are divided between patient centered standards and organization centred standards. Read More>>>
Wholesaler with drug meant for defence sector booked in Pune
Article contributed by Deepak Pranjivan, Mumbai
PUNE: Officials of the Food and Drug Administration (FDA) on Monday found one more drug wholesaler in the city involved in purchase and sale of medicines exclusively meant for the defence sector. With this, the number of drug traders found to be involved in the illegal trade in Pune has gone up to seven in the past 15 days. The officials seized drug stock worth Rs3.46 lakh, mainly comprising imported anti-diabetes and anti-hypertensive tablets meant for defence personnel, during this period.
Ms. Kavya Tripathi, ChandigarhThe PSM-India Newsletter team provided me with timely and immediate responses and delivered exactly the information that I was looking for – great job. Thank you very much.
Mr. Raj Aryan, Jaipur The newsletter delivered are of good quality and are very informative. Good work!
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.